World's Best Scientists 2026 revealed!
Chipepo Kankasa

Chipepo Kankasa

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Microbiology 45 5041 4649 1 1 148 6965

Chipepo Kankasa publications per year

The chart shows the history of publications by Chipepo Kankasa between 1998 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Chipepo Kankasa published across 28 years, from 1998 to 2025, averaging 6.2 papers a year. Output peaked at 16 publications in 2010. 5 of the 174 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1998 to 2025. Vertical axis: number of publications, 0 to 16. Peak 16 publications in 2010. 1998: 1 publication 1999: 1 publication 2000: 0 publications 2001: 2 publications 2002: 1 publication 2003: 2 publications 2004: 3 publications 2005: 9 publications 2006: 9 publications 2007: 10 publications 2008: 13 publications 2009: 10 publications 2010: 16 publications 2011: 7 publications 2012: 11 publications 2013: 9 publications 2014: 7 publications 2015: 3 publications 2016: 7 publications 2017: 9 publications 2018: 5 publications 2019: 5 publications 2020: 14 publications 2021: 6 publications 2022: 2 publications 2023: 7 publications 2024: 4 publications 2025: 1 publication
1998 2025

174 publications in total across all disciplines

View publications per year as a table
Chipepo Kankasa: publications per year, 1998 to 2025
Year Publications
1998 1
1999 1
2000 0
2001 2
2002 1
2003 2
2004 3
2005 9
2006 9
2007 10
2008 13
2009 10
2010 16
2011 7
2012 11
2013 9
2014 7
2015 3
2016 7
2017 9
2018 5
2019 5
2020 14
2021 6
2022 2
2023 7
2024 4
2025 1
Total 174
Download as CSV

Chipepo Kankasa publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Chipepo Kankasa sits on this spectrum.

No. of scientists
50 100 150 200 250
Bar chart with 64 bars. Horizontal axis: publications, 55–64 to 679+. Vertical axis: number of scientists, 0 to 288. Most scientists, 288, have 135–144 publications. The last bar groups every scientist with 679 publications or more. The highlighted bar, 145–154 publications, is where this scientist sits. 55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55–64 publications 679+

This scientist: 148 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

View publications distribution as a table
Number of Microbiology scientists by publication count, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
Publications Scientists This scientist
55–64 8
65–74 29
75–84 55
85–94 112
95–104 137
105–114 190
115–124 235
125–134 234
135–144 288
145–154 265 148
155–164 264
165–174 253
175–184 276
185–194 190
195–204 234
205–214 208
215–224 198
225–234 155
235–244 161
245–254 160
255–264 146
265–274 139
275–284 148
285–294 115
295–304 96
305–314 88
315–324 106
325–334 65
335–344 76
345–354 64
355–364 62
365–374 65
375–384 61
385–394 34
395–404 44
405–414 36
415–424 35
425–434 29
435–444 33
445–454 34
455–464 25
465–474 26
475–484 20
485–494 19
495–504 16
505–514 17
515–524 23
525–534 14
535–544 14
545–554 18
555–564 12
565–574 7
575–584 9
585–594 9
595–604 9
605–614 7
615–624 9
625–634 7
635–644 4
645–654 5
655–664 6
665–674 7
675–678 3
679+ 99
Download as CSV

Chipepo Kankasa D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Chipepo Kankasa sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 88 bars. Horizontal axis: D-Index, 40 to 127+. Vertical axis: number of scientists, 0 to 162. Most scientists, 162, have 58 D-Index. The last bar groups every scientist with 127 D-Index or more. The highlighted bar, 45 D-Index, is where this scientist sits. 40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 45 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

View D-Index distribution as a table
Number of Microbiology scientists by D-index, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
D-Index Scientists This scientist
40 30
41 86
42 90
43 117
44 122
45 123 45
46 108
47 110
48 106
49 109
50 129
51 111
52 116
53 127
54 134
55 134
56 112
57 136
58 162
59 151
60 139
61 123
62 126
63 144
64 109
65 103
66 124
67 112
68 103
69 131
70 94
71 93
72 96
73 92
74 80
75 66
76 87
77 60
78 73
79 59
80 57
81 55
82 47
83 77
84 50
85 45
86 42
87 41
88 32
89 38
90 35
91 34
92 27
93 26
94 33
95 22
96 37
97 22
98 21
99 22
100 30
101 16
102 20
103 17
104 19
105 16
106 19
107 18
108 14
109 10
110 9
111 7
112 11
113 6
114 15
115 10
116 12
117 7
118 10
119 10
120 11
121 2
122 7
123 12
124 5
125 9
126 6
127+ 95
Download as CSV

Overview

Chipepo Kankasa is affiliated with the University of Zambia in Zambia and is engaged in research primarily within the field of Medicine. Their work focuses on several subfields including Infectious Diseases, Epidemiology, General Health Professions, Emergency Medicine, and Virology.

The scientist's main research topics include:

  • HIV/AIDS Research and Interventions
  • Adolescent Sexual and Reproductive Health
  • HIV-related Health Complications and Treatments
  • Cytomegalovirus and Herpesvirus Research
  • HIV Research and Treatment
  • Pneumocystis jirovecii Pneumonia Detection and Treatment
  • Tuberculosis Research and Epidemiology

Recent published papers involving Chipepo Kankasa include:

  • "Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial" (2024), published in The Lancet
  • "Relationships Between Maternal Antibody Responses and Early Childhood Infection With Kaposi Sarcoma-Associated Herpesvirus" (2020), published in The Journal of Infectious Diseases
  • "A Randomized Trial of Point-of-Care Early Infant Human Immunodeficiency Virus (HIV) Diagnosis in Zambia" (2021), published in Clinical Infectious Diseases
  • "Impact of the COVID-19 Pandemic on Tuberculosis Testing and Treatment at a Tertiary Hospital in Zambia" (2023), published in American Journal of Tropical Medicine and Hygiene
  • "Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso" (2021), published in Contemporary Clinical Trials

Frequent co-authors collaborating with Kankasa are:

  • Jean-Pierre Molès
  • Philippe Van de Perre
  • Nicolas Nagot
  • Thorkild Tylleskär
  • Mwiya Mwiya

Chipepo Kankasa has contributed publications to a range of journals, with several recurring venues:

  • Journal of Clinical Medicine
  • Research Square (Research Square)
  • The Lancet
  • American Journal of Tropical Medicine and Hygiene
  • Contemporary Clinical Trials

Best Publications

  • Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.

    Carolyn Bolton-Moore;Mwangelwa Mubiana-Mbewe;Ronald A. Cantrell;Ronald A. Cantrell;Namwinga Chintu

  • Effects of early, abrupt weaning on HIV-free survival of children in Zambia.

    Louise Kuhn;Grace M. Aldrovandi;Moses Sinkala;Chipepo Kankasa

  • Exclusive breastfeeding promotion by peer counsellors in sub-Saharan Africa (PROMISE-EBF) : a cluster-randomised trial

    Thorkild Tylleskär;Debra Jackson;Nicolas Meda;Ingunn Marie S Engebretsen

  • Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study.

    Laura K. Murray;Katherine Semrau;Ellen McCurley;Donald M. Thea

  • Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?

    Louise Kuhn;Prisca Kasonde;Moses Sinkala;Chipepo Kankasa

  • Women in couples antenatal HIV counseling and testing are not more likely to report adverse social events.

    Katherine Semrau;Louise Kuhn;Cheswa Vwalika;Prisca Kasonde

  • High uptake of exclusive breastfeeding and reduced early post-natal HIV transmission.

    Louise Kuhn;Moses Sinkala;Chipepo Kankasa;Katherine Semrau

  • Molecularly Cloned SHIV-1157ipd3N4: a Highly Replication- Competent, Mucosally Transmissible R5 Simian-Human Immunodeficiency Virus Encoding HIV Clade C env

    R. J. Song;A.-L. Chenine;R. A. Rasmussen;C. R. Ruprecht

  • Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia

    Jeffrey S. A. Stringer;Moses Sinkala;Moses Sinkala;Moses Sinkala;Courtney C. Maclean;Jens Levy;Jens Levy

  • Human milk oligosaccharide concentration and risk of postnatal transmission of HIV through breastfeeding

    Lars Bode;Louise Kuhn;Hae-Young Kim;Lauren Hsiao

  • Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial

    Benjamin H Chi;Benjamin H Chi;Moses Sinkala;Felistas Mbewe;Ronald A Cantrell;Ronald A Cantrell

  • Growth faltering due to breastfeeding cessation in uninfected children born to HIV-infected mothers in Zambia

    Stephen Arpadi;Ashraf Fawzy;Grace M Aldrovandi;Chipepo Kankasa

  • Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers.

    Louise Kuhn;Moses Sinkala;Katherine Semrau;Chipepo Kankasa

  • Breastmilk cell trafficking induces microchimerism‐mediated immune system maturation in the infant

    Jean Pierre Molès;Edouard Tuaillon;Chipepo Kankasa;Anne Sophie Bedin

  • Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility.

    Chipepo Kankasa;Rosalind J Carter;Nancy Briggs;Marc Bulterys

  • Early Weaning Increases Diarrhea Morbidity and Mortality Among Uninfected Children Born to HIV-infected Mothers in Zambia

    Ashraf Fawzy;Stephen Arpadi;Chipepo Kankasa;Moses Sinkala

  • Seroprevalence of Human Herpesvirus 8 among Zambian Women of Childbearing Age without Kaposi's Sarcoma (KS) and Mother-Child Pairs with KS

    Jun He;Ganapati Bhat;Chipepo Kankasa;Chifumbe Chintu

  • Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine.

    Benjamin H. Chi;Moses Sinkala;Elizabeth M. Stringer;Elizabeth M. Stringer;Ronald A. Cantrell;Ronald A. Cantrell

  • Distribution of Kaposi Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 in Maternal Saliva and Breast Milk in Zambia: Implications for Transmission

    Brad P. Brayfield;Chipepo Kankasa;John T. West;Jubra Muyanga

  • Vertical transmission of Kaposi's sarcoma‐associated herpesvirus

    Hamakwa Mantina;Chipepo Kankasa;Winslow Klaskala;Brad Brayfield

  • Alpha-defensins in the prevention of HIV transmission among breastfed infants

    Louise Kuhn;Daria Trabattoni;Chipepo Kankasa;Katherine Semrau

  • Extended Pre-exposure Prophylaxis With Lopinavir-Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission Through Breastfeeding Up to 50 Weeks in Infants in Africa (ANRS 12174): A Randomised Controlled Trial

    Nicolas Nagot;Chipepo Kankasa;James K. Tumwine;Nicolas Meda

  • Predictors of Nonadherence to Single-Dose Nevirapine Therapy for the Prevention of Mother-to-Child HIV Transmission

    Sandra Albrecht;Katherine Semrau;Prisca Kasonde;Moses Sinkala

  • The Impact of Daily Cotrimoxazole Prophylaxis and Antiretroviral Therapy on Mortality and Hospital Admissions in HIV-Infected Zambian Children

    A. Sarah Walker;Veronica Mulenga;Deborah Ford;Desire Kabamba

Frequent Co-Authors

Grace M. Aldrovandi
Grace M. Aldrovandi University of California, Los Angeles
Charles Wood
Charles Wood University of Nebraska–Lincoln
Diana M. Gibb
Diana M. Gibb University College London
Sten H. Vermund
Sten H. Vermund Yale University
David M. Burger
David M. Burger Radboud University
Carl Lombard
Carl Lombard Stellenbosch University
G Justus Hofmeyr
G Justus Hofmeyr University of the Witwatersrand
James I. Mullins
James I. Mullins University of Washington
Stéphane Blanche
Stéphane Blanche Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Microbiology in the USA, exploring related online degrees can open diverse career opportunities beyond traditional laboratory roles. One promising field is Health Information Management, which combines healthcare knowledge with data management skills. Those interested can explore health information management salary to understand the financial benefits associated with this career path.

Finding the right education is key. Many reputable institutions offer online health information management degree programs cahiim accredited, ensuring quality training tailored to industry standards. These programs often provide flexible learning suited for working professionals or those transitioning from Biology or Microbiology backgrounds.

For quicker credentialing, individuals may consider the shortest online medical billing and coding certificate programs, which can be completed rapidly and prepare students for essential roles in healthcare administration.

Moreover, a range of medical degrees online that pay well are available, offering alternative routes to high-paying healthcare careers. Exploring these options allows Microbiology students to diversify their skill sets and improve employment prospects in the evolving medical field.

Best Scientists Citing Chipepo Kankasa

Trending Scientists

Recently Published Articles